Find Imepitoin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 188116-07-6, Awd 131-138, Imepitoin [inn], Imepition, Awd131-138, 1-(4-chlorophenyl)-4-morpholin-4-yl-5h-imidazol-2-one
Molecular Formula
C13H14ClN3O2
Molecular Weight
279.72  g/mol
InChI Key
IQHYCZKIFIHTAI-UHFFFAOYSA-N
FDA UNII
19V39682LI

Imepitoin
1 2D Structure

Imepitoin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-(4-chlorophenyl)-5-morpholin-4-yl-4H-imidazol-2-one
2.1.2 InChI
InChI=1S/C13H14ClN3O2/c14-10-1-3-11(4-2-10)17-9-12(15-13(17)18)16-5-7-19-8-6-16/h1-4H,5-9H2
2.1.3 InChI Key
IQHYCZKIFIHTAI-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1COCCN1C2=NC(=O)N(C2)C3=CC=C(C=C3)Cl
2.2 Other Identifiers
2.2.1 UNII
19V39682LI
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Awd 131-138

2. Awd131-138

3. Elb138

4. Pexion

2.3.2 Depositor-Supplied Synonyms

1. 188116-07-6

2. Awd 131-138

3. Imepitoin [inn]

4. Imepition

5. Awd131-138

6. 1-(4-chlorophenyl)-4-morpholin-4-yl-5h-imidazol-2-one

7. 2h-imidazol-2-one, 1-(4-chlorophenyl)-1,5-dihydro-4-(4-morpholinyl)-

8. Add-233089

9. Awd-131-138

10. 1-(4-chlorophenyl)-4-morpholino-1h-imidazol-2(5h)-one

11. Imepitoin (awd 131-138)

12. Elb-138

13. 1-(4-chlorophenyl)-1,5-dihydro-4-(4-morpholinyl)-2h-imidazol-2-one

14. 19v39682li

15. Pexion

16. 1-(4-chlorophenyl)-4-(morpholin-4-yl)-2,5-dihydro-1h-imidazol-2-one

17. 3-(4-chlorophenyl)-5-morpholin-4-yl-4h-imidazol-2-one

18. Unii-19v39682li

19. Imepitoin [mi]

20. Awd 131-138(imepitoin)

21. Chembl204240

22. Schembl1645360

23. Zinc6856

24. Dtxsid50172160

25. Ex-a261

26. Hms3886o19

27. Bcp08396

28. Mfcd18450225

29. S5319

30. Akos024258133

31. Ccg-267239

32. Cs-1733

33. Imepitoin [ema Epar Veterinary]

34. Ncgc00371144-02

35. Ncgc00371144-03

36. Ac-36287

37. As-72354

38. Da-33561

39. Hy-14953

40. Ft-0700248

41. J3.500.192a

42. A13726

43. J-690252

44. Q27252133

45. 1-(4-chlorophenyl)-4-(morpholin-4-yl)-1,5-dihydro-2h-imidazol-2-one

2.4 Create Date
2005-08-09
3 Chemical and Physical Properties
Molecular Weight 279.72 g/mol
Molecular Formula C13H14ClN3O2
XLogP31.2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass279.0774544 g/mol
Monoisotopic Mass279.0774544 g/mol
Topological Polar Surface Area45.1 Ų
Heavy Atom Count19
Formal Charge0
Complexity374
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

For the reduction of the frequency of generalised seizures due to idiopathic epilepsy in dogs for use after careful evaluation of alternative treatment options.


5 Pharmacology and Biochemistry
5.1 ATC Code

QN03AX90


Listed Suppliers

read-more
read-more

01

Suanfarma

Spain
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSuanfarma, at the Core of a Better Life.

Flag Spain
Digital Content Digital Content

Imepitoin

About the Company : Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical indu...

Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical industry innovatively & sustainably. Backed by a robust global network of 12 strategically located local offices, we cater to the needs of over 400 active customers in 70+ countries. At Suanfarma we offer our CDMO capacity for fermentation & chemical synthesis projects, offering a One Stop Shop service with a solid track record, & which allows us to achieve success in the development, scaling, manufacturing, & commercialization of an API, either innovative or generic.
Suanfarma

02

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

Imepitoin

About the Company : Alivira Animal Health Limited has emerged as India's largest and 1st Global integrated animal health company specialising in manufacturing of Active Pharmaceutical Ingredients (API...

Alivira Animal Health Limited has emerged as India's largest and 1st Global integrated animal health company specialising in manufacturing of Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF).Our logotype is inspired by nature and its different forms and shapes. From a microscopic view to the skin texture, footprint of a chosen animal. The circular shape evokes the idea of protection and control. It’s a closed and perfect shape that is naturally balanced, reminiscing the brand idea “Animals source of health.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty